Watch NBC Bay Area News free wherever you are Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for the popular injection, such as those with Medicare
The companies realize that the market is constrained by cost, and reducing the price is the fastest way to unlock millions of new users
Liu D, Zhou C, Wang X, Luo Z, Xu R, Huo S, et al
$2,100 beneficiary OOP cap applies in 2026
GLP-1 receptor agonists and the path to sustainable obesity care
To protect itself, the pea-size lens has one of the highest concentrations of glutathione found anywhere in the body